Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GRCL

Gracell Biotechnologies (GRCL) Stock Price, News & Analysis

Gracell Biotechnologies logo

About Gracell Biotechnologies Stock (NASDAQ:GRCL)

Advanced Chart

Key Stats

Today's Range
$10.25
$10.25
50-Day Range
$10.14
$10.35
52-Week Range
$1.40
$10.44
Volume
N/A
Average Volume
1.32 million shs
Market Capitalization
$744.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GRCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gracell Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

GRCL Stock News Headlines

GRCL Mar 2024 10.000 call(CONTR
Gracell Biotechnologies Acquisition Completed
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Gracell Biotechnologies Acquisition Completed
Gracell Biotechnologies Inc. (GRCL)
See More Headlines

GRCL Stock Analysis - Frequently Asked Questions

Gracell Biotechnologies Inc. (NASDAQ:GRCL) posted its quarterly earnings data on Sunday, November, 14th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.18. The business earned $0.06 million during the quarter.

Gracell Biotechnologies (GRCL) raised $150 million in an initial public offering on Friday, January 8th 2021. The company issued 8,800,000 shares at a price of $16.00-$18.00 per share. Citigroup, Jefferies, Piper Sandler and Wells Fargo Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gracell Biotechnologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Adobe (ADBE).

Company Calendar

Last Earnings
11/14/2021
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:GRCL
CIK
1826492
Fax
N/A
Employees
314
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$88.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$60 thousand
Price / Sales
12,415.83
Price / Cash Flow
N/A
Book Value
$2.95 per share
Price / Book
3.47

Miscellaneous

Free Float
52,328,000
Market Cap
$744.95 million
Optionable
Optionable
Beta
-0.33
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:GRCL) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners